ECCMID 26th (2016)

Drupal spam blocked by CleanTalk.
Title Content type
Candida bloodstream infections in a Greek tertiary hospital: 5-year survey – epidemiology and in vitro antifungal susceptibility profiles (click for details)
Utility of the IA diagnosis biomarker bis(methylthio)gliotoxin to monitor voriconazole treatment (click for details)
Pharmacokinetics of anidulafungin in critically ill patients in the intensive care unit with suspected or proven invasive fungal infections (click for details)
Population pharmacokinetics of micafungin in plasma and burn eschar in severely burned critically-ill patients (click for details)
Cost-effectiveness analysis of prophylaxis therapies for invasive fungal infections following allogeneic haematopoietic stem cell transplantation in Mexico (click for details)
A point-prevalence study of antifungal therapy in Greek hospitals (click for details)
Cost-effectiveness of tablets of posaconazole compared to oral fluconazole or itraconazole in the prevention of invasive fungal diseases among high-risk neutropenic patients with either acute myelogenous leukaemia or myelodysplastic syndrome in Spain (click for details)
Treatment of recurrent esophageal candidiasis (rec) in hiv-negative patients in Saint Petersburg, Russia (click for details)
Liposomal amphotericin B shows poor antifungal activity against Candida tropicalis biofilms (click for details)
A randomized controlled trial comparing voriconazole and placebo for antifungal prophylaxis in patients with acute myeloid leukaemia receiving chemotherapy (click for details)


Subscribe to ECCMID 26th (2016)